Liver diseases are rising globally; early diagnosis and minimally invasive techniques by Dr Vipulroy Rathod help prevent ...

Background: FibroTest (FT) is the most frequently used serum fibrosis marker and consists of an algorithm of five fibrosis markers (alfa2-macroglobulin, apolipoproteinA1, haptoglobin, GGT, bilirubin).

Liver fibrosis, a hallmark of chronic liver disease, has traditionally been staged by invasive biopsy, but magnetic resonance imaging (MRI) offers a suite of non-invasive approaches to characterise ...

Although liver biopsy is a well-established technique to assess fibrosis it has several limitations, including invasive nature, semi-quantitative assessment methods, significant sampling and observer ...

Zabopegdutide is a unique, liver-targeted GLP-1 /glucagon receptor agonist with a dominant 11:1 GLP-1 -to-glucagon potency ratio, which provides both metabolic and hepatic benefits while maintaining a ...

A substantial proportion of asymptomatic individuals in Greater Vancouver have undetected MASLD and significant fibrosis. Early identification of high-risk groups may support broader implementation of ...

BOSTON — In the staging of liver fibrosis in the post-liver transplant setting, readings from noninvasive tests commonly have major discrepancies when compared with liver biopsy results, particularly ...

E-Scopics, a pioneer in advanced point-of-care liver imaging, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its new Hepatoscope-Derived Fat Fraction ...

Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. Liver fibrosis is scarring that ...

In an interim analysis of an ongoing global trial, semaglutide resolved steatohepatitis in 63% of patients and reduced liver fibrosis, while also promoting weight loss and improving metabolic health ...